Live

Apellis Pharmaceuticals

1 articles

Apellis to Highlight Complement Science Portfolio at TD Cowen Healthcare Forum

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 23·Na

Apellis to Highlight Complement Science Portfolio at TD Cowen Healthcare Forum

Apellis will discuss its complement-targeted drug portfolio at TD Cowen Healthcare Forum in March 2026, highlighting its approved therapies for eye and kidney diseases.

APLSbiopharmaceuticalApellis Pharmaceuticals